Your browser doesn't support javascript.
loading
Preclinical and Clinical Resistance Profile of EDP-239, a Novel Hepatitis C Virus NS5A Inhibitor.
Owens, Christopher M; Brasher, Bradley B; Polemeropoulos, Alex; Rhodin, Michael H J; McAllister, Nicole; Wong, Kelly A; Jones, Christopher T; Jiang, Lijuan; Lin, Kai; Or, Yat Sun.
Affiliation
  • Owens CM; ENANTA Pharmaceuticals Inc., Watertown, Massachusetts, USA cmowens@gmail.com.
  • Brasher BB; ENANTA Pharmaceuticals Inc., Watertown, Massachusetts, USA.
  • Polemeropoulos A; ENANTA Pharmaceuticals Inc., Watertown, Massachusetts, USA.
  • Rhodin MH; ENANTA Pharmaceuticals Inc., Watertown, Massachusetts, USA.
  • McAllister N; ENANTA Pharmaceuticals Inc., Watertown, Massachusetts, USA.
  • Wong KA; Novartis Institutes for Biomedical Research, Inc., Emeryville, California, USA.
  • Jones CT; Novartis Institutes for Biomedical Research, Inc., Emeryville, California, USA.
  • Jiang L; ENANTA Pharmaceuticals Inc., Watertown, Massachusetts, USA.
  • Lin K; ENANTA Pharmaceuticals Inc., Watertown, Massachusetts, USA.
  • Or YS; ENANTA Pharmaceuticals Inc., Watertown, Massachusetts, USA.
Antimicrob Agents Chemother ; 60(10): 6216-26, 2016 10.
Article in En | MEDLINE | ID: mdl-27503644

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Valine / Benzimidazoles / Viral Nonstructural Proteins / Hepacivirus / Hepatitis C, Chronic / Drug Resistance, Viral Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: Antimicrob Agents Chemother Year: 2016 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Valine / Benzimidazoles / Viral Nonstructural Proteins / Hepacivirus / Hepatitis C, Chronic / Drug Resistance, Viral Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: Antimicrob Agents Chemother Year: 2016 Type: Article Affiliation country: United States